Hospital Quironsalud Malaga — Clinical Trial Site

73 Registered trials

40 Currently recruiting

Organisation

Hospital Quironsalud Malaga

Location

Malaga, Spain

Identifier

ORG-100042532

Address

Avenida Imperio Argentina 1, 29004, Spain

Departments

1606:Oncología
7002: Oncology
7009: Servicio de Oncologia Medica
Allergology
Allergy
Assisted Reproduction
Cardiology
Cirugía
Departamento de Ginecología General
EECC Unidad Integral del Cancer
Endocrinology and metabolism
Endocrinology and Nutrition
ESP018: Oncología
Gynaecology and obstetrics
Gynecology and Obstetrics
Gynecology Service
Haematology
Internal Medicine
Medical Oncology
NA
Neurology
Obstetricia
Oncología
oncología médica
Oncology
Pediatrics
Psiquiatría
Respiratory
Rheumatology
Rheumatology Department
Servicio de digestivo
Servicio de Endocrinologia

Clinical trials at this site (73)

Search interface

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies Ended

2024-511453-22-00 Participants with Advanced Solid Malignancies 1 2024-10-28
Clinical trial to assess the efficacy and safety of a vaccine for grasses and olive tree allergy Ended

2024-514525-34-00 Aetiological treatment of moderate-severe intermitent o 5 2024-08-18
A Study Evaluating Pharmacokinetic similarity between ABP 234 and Keytruda® (pembrolizumab) in Subjects with Early-stage Non-squamous Non-sm… Ended

2023-508359-38-00 Early-stage Non-squamous Non-small Cell Lung Cancer 5 2024-06-05
Phase 3 study of adjuvant V940 and Pembrolizumab in resected Stage II, IIIA, IIIB NSCLC Ended

2023-504923-20-00 Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer 5 2024-04-04
Study with Various Immunotherapy Treatments in Participants With Lung Cancer Ended

2022-502916-35-01 Advanced Non-Small Cell Lung Cancer 4 2024-03-27
Study which tests 3 medicines (SB27, EU sourced Keytruda, and US sourced Keytruda) in early or locally advanced non-small cell lung cancer p… Ended

2023-507438-25-00 Non-small cell lung cancer 2 2024-02-28
A study of sigvotatug vedotin versus docetaxel in previously treated non-small cell lung cancer (Be6A Lung-01) Ended

2023-503827-25-01 Non-Small Cell Lung Cancer (NSCLC) 5 2024-02-16
Study which tests 2 medications (SB27, Keytruda) to compare how effective, safe and well tolerated in a large number of metastatic non-squam… Ended

2023-507448-36-00 Non-small Cell Lung Cancer 5 2024-02-16
DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ended

2024-513867-19-00 metastatic Castration-Resistant Prostate Cancer (mCRPC) 5 2019-01-31
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Ended

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastati… Ended

2023-506882-70-00 Non-small-cell lung cancer 5 2024-08-16
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer Ended

2023-504630-22-00 Non-Small Cell Lung Cancer 7 2024-04-19
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee (TRIUMPH-4) Ended

2023-503660-17-00 Osteoarthritis, Knee 5 2023-10-09
A Ph3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia: The ENTRUST study Ended

2023-503576-25-00 Severe Hypertriglyceridemia 5 2023-09-22
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Acute vulvovaginal candidiasis 4 2023-09-18
Phase 3 Study Comparing Zimberelimab with Domvanalimab to Pembrolizumab in Advanced Non-Small Cell Lung Cancer Ended

2022-503071-28-00 Squamous Non-small cell Lung Cancer 5 2023-08-31
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 1… Ended

2022-502023-21-00 Prevention of pregnancy 5 2023-07-12
A Phase 3, 52-Week, Randomized, Efficacy and Safety Study with Open-Label Extension of BLU-5937 in Adult Participants with Refractory or Une… Ended

2024-513460-26-00 Refractory Chronic Cough, Including Unexplained Chronic 5 2023-03-29
Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after… Ended

2024-510980-40-00 Small cell lung cancer 3 2023-03-09
Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended

2023-508820-37-00 Cytomegalovirus Infection (CMV) 5 2022-02-03
MENACWY=MEN7B-003 Ended

2023-506449-40-00 Infections, Meningococcal 9 2021-11-29
A multi site clinical trial to evaluate the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain Ended

2024-514934-19-00 Post-surgical neuropathic pain 5 2021-11-08
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan… Ended

2024-512227-36-00 Advanced solid tumors 9 2021-07-28
LSTA1 Phase 2a basket trial in advanced solid tumors Ended

2023-503740-14-00 Head and neck cancer 4